Shiomi Hiroki, Morimoto Takeshi, Furukawa Yutaka, Nakagawa Yoshihisa, Sakata Ryuzo, Okabayashi Hitoshi, Hanyu Michiya, Shimamoto Mitsuomi, Nishiwaki Noboru, Komiya Tatsuhiko, Kimura Takeshi
Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.
Circ J. 2015;79(6):1282-9. doi: 10.1253/circj.CJ-15-0034. Epub 2015 Mar 30.
Studies evaluating long-term (≥5 years) outcome of percutaneous coronary intervention (PCI) compared with coronary artery bypass grafting (CABG) in patients with unprotected left main coronary artery disease (ULMCAD) are still limited, despite concerns for late adverse events after drug-eluting stents implantation.
We identified 1,004 patients with ULMCAD (PCI: n=364, CABG: n=640) among 15,939 patients with first coronary revascularization enrolled in the CREDO-Kyoto PCI/CABG registry cohort-2. The primary outcome measure in the current analysis was a composite of death, myocardial infarction, and stroke (death/MI/stroke). The cumulative 5-year incidence of and the adjusted risk for death/MI/stroke were significantly higher in the PCI group than in the CABG group (34.5% vs. 24.1%, log-rank P<0.001, adjusted hazard ratio (HR): 1.48 [95% confidence interval (CI): 1.07-2.05, P=0.02]). The adjusted risks for all-cause death was not significantly different between the 2 groups. Regarding the stratified analysis by the SYNTAX score, the adjusted risk for death/MI/stroke was not significantly different between the 2 groups in patients with low (<23) or intermediate (23-33) SYNTAX score, whereas it was significantly higher in the PCI group than in the CABG group in patients with high (≤33) SYNTAX score.
CABG as compared with PCI was associated with better long-term outcome in patients with ULMCAD, especially those with high anatomical complexity.
尽管对药物洗脱支架植入后的晚期不良事件存在担忧,但评估经皮冠状动脉介入治疗(PCI)与冠状动脉旁路移植术(CABG)治疗无保护左主干冠状动脉疾病(ULMCAD)患者的长期(≥5年)结局的研究仍然有限。
在纳入CREDO-Kyoto PCI/CABG注册队列2的15939例首次进行冠状动脉血运重建的患者中,我们识别出1004例ULMCAD患者(PCI组:n = 364,CABG组:n = 640)。当前分析的主要结局指标是死亡、心肌梗死和中风的复合指标(死亡/心肌梗死/中风)。PCI组死亡/心肌梗死/中风的累积5年发生率和调整后的风险显著高于CABG组(34.5%对24.1%,对数秩检验P<0.001,调整后的风险比(HR):1.48 [95%置信区间(CI):1.07 - 2.05,P = 0.02])。两组间全因死亡的调整风险无显著差异。关于按SYNTAX评分进行的分层分析,在SYNTAX评分低(<23)或中等(23 - 33)的患者中,两组间死亡/心肌梗死/中风的调整风险无显著差异,而在SYNTAX评分高(≤33)的患者中,PCI组的调整风险显著高于CABG组。
与PCI相比,CABG与ULMCAD患者的更好长期结局相关,尤其是那些解剖复杂性高的患者。